The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis

BackgroundChimeric antigen receptor (CAR) T-cell therapy has attracted considerable attention since its recent endorsement by the Food and Drug Administration, as it has emerged as a promising immunotherapeutic modality within the landscape of oncology. This study explores the prognostic utility of...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Dhuha Ali Al-Adhami, Mike Sathekge, Henry Hee-Seung Bom, Mohammad Ma’koseh, Asem Mansour, Hikmat Abdel-Razeq, Kamal Al-Rabi, Enrique Estrada-Lobato, Maysaa Al-Hussaini, Ismail Matalka, Zaid Abdel Rahman, Stephano Fanti
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2024-09-01
Serie:	Frontiers in Immunology
Soggetti:	CAR T-cell chimeric antigen receptor CAR T cell therapy immunotherapy systematic review meta-analysis
Accesso online:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1424269/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!